- Home
- A-Z Publications
- Current Neuropharmacology
- Previous Issues
- Volume 20, Issue 2, 2022
Current Neuropharmacology - Volume 20, Issue 2, 2022
Volume 20, Issue 2, 2022
-
-
Sleep, Narcolepsy, and Sodium Oxybate
More LessSodium oxybate (SO) has been in use for many decades to treat narcolepsy with cataplexy. It functions as a weak GABAB agonist but also as an energy source for the brain as a result of its metabolism to succinate and as a powerful antioxidant because of its capacity to induce the formation of NADPH. Its actions at thalamic GABAB receptors can induce slow-wave activity, while its actions at GABAB receptors on monoaminerg Read More
-
-
-
Progression in Moyamoya Disease: Clinical Features, Neuroimaging Evaluation, and Treatment
Authors: Xin Zhang, Weiping Xiao, Qing Zhang, Ding Xia, Peng Gao, Jiabin Su, Heng Yang, Xinjie Gao, Wei Ni, Yu Lei and Yuxiang GuMoyamoya disease (MMD) is a chronic cerebrovascular disease characterized by progressive stenosis of the arteries of the circle of Willis, with the formation of collateral vascular network at the base of the brain. Its clinical manifestations are complicated. Numerous studies have attempted to clarify the clinical features of MMD, including its epidemiology, genetic characteristics, and pathophysiology. With the development of ne Read More
-
-
-
PLGA-Based Curcumin Delivery System: An Interesting Therapeutic Approach in the Treatment of Alzheimer’s Disease
Progressive degeneration and dysfunction of the nervous system because of oxidative stress, aggregations of misfolded proteins, and neuroinflammation are the key pathological features of neurodegenerative diseases. Alzheimer's disease is a chronic neurodegenerative disorder driven by uncontrolled extracellular deposition of β-amyloid (Aβ) in the amyloid plaques and intracellular accumulation of hyperphospho Read More
-
-
-
Flavonoids, the Family of Plant-Derived Antioxidants Making Inroads into Novel Therapeutic Design Against Ionizing Radiation-Induced Oxidative Stress in Parkinson’s Disease
Authors: Tapan Behl, Gagandeep Kaur, Aayush Sehgal, Gokhan Zengin, Sukhbir Singh, Amirhossein Ahmadi and Simona BungauBackground: Ionizing radiation from telluric sources is unceasingly an unprotected pitfall to humans. Thus, the foremost contributors to human exposure are global and medical radiations. Various evidences assembled during preceding years reveal the pertinent role of ionizing radiation- induced oxidative stress in the progression of neurodegenerative insults, such as Parkinson’s disease, which have been contributing to in Read More
-
-
-
In Vitro, In Vivo and Ex Vivo Models for Peripheral Nerve Injury and Regeneration
Authors: Andrew Li, Clifford Pereira, Elise E. Hill, Olivia Vukcevich and Aijun WangPeripheral Nerve Injuries (PNI) frequently occur secondary to traumatic injuries. Recovery from these injuries can be expectedly poor, especially in proximal injuries. In order to study and improve peripheral nerve regeneration, scientists rely on peripheral nerve models to identify and test therapeutic interventions. In this review, we discuss the best described and most commonly used peripheral nerve models that scientists Read More
-
-
-
cGAS-STING-mediated IFN-I Response in Host Defense and Neuroinflammatory Diseases
Authors: Kai Chen, Chuan Lai, Ying Su, Wen D. Bao, Liu Nan Yang, Ping-Ping Xu and Ling-Qiang ZhuThe presence of foreign or misplaced nucleic acids is a dangerous signal that triggers innate immune responses by activating cytosolic DNA sensor cyclic GMP-AMP synthase (cGAS) and binding to its downstream signaling effector stimulator of interferon genes (STING). Then the cGAS-STING pathway activation links nucleic acid-sensing to immune responses and pathogenic entities clearance. However, the overactivation of thi Read More
-
-
-
Interleukin-17A in Alzheimer’s Disease: Recent Advances and Controversies
Authors: Xin-Zhu Yan, Laijun Lai, Qiang Ao, Xiao-Hong Tian and Yan-Hui ZhangAlzheimer’s disease (AD) is a progressive neurodegenerative disease that mainly affects older adults. Although the global burden of AD is increasing year by year, the causes of AD remain largely unknown. Numerous basic and clinical studies have shown that interleukin-17A (IL-17A) may play a significant role in the pathogenesis of AD. A comprehensive assessment of the role of IL-17A in AD would benefit the diagnosis, understa Read More
-
-
-
Depression and Pain: Use of Antidepressants
Background: Emotional disorders are common comorbid affectations that exacerbate the severity and persistence of chronic pain. Specifically, depressive symptoms can lead to an excessive duration and intensity of pain. Clinical and preclinical studies have been focused on the underlying mechanisms of chronic pain and depression comorbidity and the use of antidepressants to reduce pain. Aim: This review provides an ov Read More
-
-
-
Changes in Histaminergic System in Neuropsychiatric Disorders and the Potential Treatment Consequences
Authors: Ling Shan and Dick F. SwaabIn contrast to that of other monoamine neurotransmitters, the association of the histaminergic system with neuropsychiatric disorders is not well documented. In the last two decades, several clinical studies involved in the development of drugs targeting the histaminergic system have been reported. These include the H3R-antagonist/inverse agonist, pitolisant, used for the treatment of excessive sleepiness in narcolepsy, and Read More
-
-
-
SARS-Cov-2 Damage on the Nervous System and Mental Health
The World Health Organization declared the pandemic situation caused by SARSCoV- 2 (Severe Acute Respiratory Syndrome Coronavirus-2) in March 2020, but the detailed pathophysiological mechanisms of Coronavirus disease 2019 (COVID-19) are not yet completely understood. Therefore, to date, few therapeutic options are available for patients with mildmoderate or serious disease. In addition to systemic and r Read More
-
-
-
Do Naturally Occurring Antioxidants Protect Against Neurodegeneration of the Dopaminergic System? A Systematic Revision in Animal Models of Parkinson's Disease
Authors: Carmen Costas and Lilian R.F. FaroParkinson’s disease (PD) is the second most common neurodegenerative disease and is characterized by a significant decrease in dopamine levels, caused by progressive degeneration of the dopaminergic neurons in the nigrostriatal pathway. Multiple mechanisms have been implicated in its pathogenesis, including oxidative stress, neuroinflammation, protein aggregation, mitochondrial dysfunction, insufficient support for neu Read More
-
-
-
Optimal Dose of Erenumab for Preventive Treatment of Episodic Migraine: A Systematic Review and Meta-Analysis
Authors: Yanbo Yang, Mingjia Chen, Da Wu, Yue Sun, Fan Jiang, Zhouqing Chen and Zhong WangBackground: Erenumab is a novel monoclonal calcitonin gene-related peptide receptor antibody that is used for the preventive treatment of migraine. Objectives: This study aimed to evaluate the overall safety, efficacy, and dose-response relationship of erenumab in patients with episodic migraine and patients with prior migraine treatment failures. Methods: We searched randomized clinical trials on PUBMED, EMB Read More
-
-
-
Erratum
Due to an oversight, the title of an editorial was the same as the title of one of the manuscripts entitled as Current and Emerging Treatments for Methamphetamine Use Disorder, and now it has been replaced with the new one entitled “Insights Into the Complexity of Methamphetamine Actions in the Brain and Periphery in the Face of a 3rd Methamphetamine Abuse Epidemic, guest-edited by Dr. Anna Moszczynska, which Read More
-
Volumes & issues
-
Volume 23 (2025)
-
Volume 22 (2024)
-
Volume 21 (2023)
-
Volume 20 (2022)
-
Volume 19 (2021)
-
Volume 18 (2020)
-
Volume 17 (2019)
-
Volume 16 (2018)
-
Volume 15 (2017)
-
Volume 14 (2016)
-
Volume 13 (2015)
-
Volume 12 (2014)
-
Volume 11 (2013)
-
Volume 10 (2012)
-
Volume 9 (2011)
-
Volume 8 (2010)
-
Volume 7 (2009)
-
Volume 6 (2008)
-
Volume 5 (2007)
-
Volume 4 (2006)
-
Volume 3 (2005)
-
Volume 2 (2004)
-
Volume 1 (2003)
Most Read This Month
Article
content/journals/cn
Journal
10
5
false
en
